Technology Platform - HANGZHOU DAC BIOTECHNOLOGY CO.,LTD

Technology Platform

As an enterprise focusing on ADC drug innovation and production, DAC Biotechnology has independently established a complete technology platform in the ADC field. It has the capabilities of new ADC drug research and development, as well as process development.

Antibody generation and analyses platform

Production and selection of innovative monoclonal antibodies that can be used for ADC through hybridoma and phage...
Small molecule drug screening platform:

Developed five categories of cytotoxic molecules with different mechanisms: Tubulysin- microtubule inhibitors; Amaniti...
Quality researches and ADC drug characterization methodology

Established a quality research system for antibodies and ADC drugs, especially the application of LC-MS technology...
ADC Drug Evaluation System

Validation of antibody and ADC functions at the molecular and cellular levels; evaluation of the efficacy and toxicity of ADC drugs in animal models, and study of the PK PD characteristics of drugs.

HANGZHOU DAC BIOTECHNOLOGY CO .,LTD

Address

Building 12, No. 260 Sixth Street, ZhengTaiZhongZi Sci &Tech Park, HEDA， Hangzhou, Zhejiang 310018, China
Telephone

0571-56050590
Email

duoxi@dacbiotech.com

Official accounts

Links

Center For DRUG EVALUTION NMPA